(2023). The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study. Plos Med, 20, e1004223. http://doi.org/10.1371/journal.pmed.1004223.
(2023). Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKI. Br J Gen Pract. http://doi.org/10.3399/bjgp.2022.0389.
(2022). Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study. Bmj, 379, e070918. http://doi.org/10.1136/bmj-2022-070918.
(2018). Association of guideline and policy changes with incidence of lifestyle advice and treatment for uncomplicated mild hypertension in primary care: a longitudinal cohort study in the Clinical Practice Research Datalink. BMJ Open. http://doi.org/10.1136/bmjopen-2018-021827.
(2018). Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension. JAMA Intern Med. http://doi.org/10.1001/jamainternmed.2018.4684.
(2020). Impact of Changes to National Hypertension Guidelines on Hypertension Management and Outcomes in the United Kingdom. Hypertension. http://doi.org/10.1161/hypertensionaha.119.13926.
(2021). Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink. BMJ Open. http://doi.org/10.1136/bmjopen-2021-050757.
(2021). Impact of changes to national guidelines on hypertension-related workload: an interrupted time series analysis in English primary care. Br J Gen Pract. http://doi.org/10.3399/bjgp21X714281.